(VIANEWS) – OKEA (OKEA.OL), BASIC-FIT (BFIT.AS), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. OKEA (OKEA.OL)
50.3% sales growth and 32.98% return on equity
OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian continental shelf. The company holds 44.56% interests in Draugen, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 6% interests in Nova, and 15% interests in Yme assets. OKEA ASA was incorporated in 2015 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, OKEA has a trailing twelve months EPS of kr6.27.
PE Ratio
OKEA has a trailing twelve months price to earnings ratio of 3.71. Meaning, the purchaser of the share is investing kr3.71 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.98%.
Volume
Today’s last reported volume for OKEA is 263816 which is 54.32% below its average volume of 577589.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Dec 1, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 17.18%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.8%, now sitting on 8.22B for the twelve trailing months.
More news about OKEA.
2. BASIC-FIT (BFIT.AS)
31.3% sales growth and 4.68% return on equity
Basic-Fit N.V., together with its subsidiaries, engages in the operation of fitness clubs. It operates 1200 clubs under Basic-Fit brand in Netherlands, Belgium, Luxembourg, Germany, France, and Spain. The company was founded in 1984 and is headquartered in Hoofddorp, the Netherlands.
Earnings Per Share
As for profitability, BASIC-FIT has a trailing twelve months EPS of €0.27.
PE Ratio
BASIC-FIT has a trailing twelve months price to earnings ratio of 101.11. Meaning, the purchaser of the share is investing €101.11 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.68%.
Yearly Top and Bottom Value
BASIC-FIT’s stock is valued at €27.30 at 11:20 EST, way below its 52-week high of €39.96 and way above its 52-week low of €23.70.
More news about BASIC-FIT.
3. NAVAMEDIC (NAVA.OL)
20.7% sales growth and 11.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 31.78. Meaning, the purchaser of the share is investing kr31.78 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.
More news about NAVAMEDIC.
4. MELHUS SPAREBANK (MELG.OL)
15.6% sales growth and 10.56% return on equity
Melhus Sparebank, a savings bank, provides various banking products and services to companies, agriculture customers, and private individuals in Norway. The company offers savings accounts; construction and business loans; mortgage, and car loans; bank guarantee, overdraft, and leasing services; and credit and bank cards. It also provides various insurance products for home, cottage, household goods, contents, drone, car, boat, other vehicles, travel, animal, children, death, health, critical illness, disabled, private, commercial, agricultural, and accident; savings and pension products; payment services; and online and mobile banking services. The company operates through branch offices in central Trondheim, Heimdal, Ler, and Korsvegen. Melhus Sparebank was founded in 1840 and is headquartered in Melhus, Norway.
Earnings Per Share
As for profitability, MELHUS SPAREBANK has a trailing twelve months EPS of kr17.12.
PE Ratio
MELHUS SPAREBANK has a trailing twelve months price to earnings ratio of 9.58. Meaning, the purchaser of the share is investing kr9.58 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.
Sales Growth
MELHUS SPAREBANK’s sales growth is 16.3% for the ongoing quarter and 15.6% for the next.
Volume
Today’s last reported volume for MELHUS SPAREBANK is 30 which is 88.46% below its average volume of 260.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 17, 2023, the estimated forward annual dividend rate is 11 and the estimated forward annual dividend yield is 6.88%.
More news about MELHUS SPAREBANK.
5. ODFJELL TECHNOLOGY (OTL.OL)
12.4% sales growth and 34.07% return on equity
Odfjell Technology Ltd., a technology and engineering company, provides well, drilling, and engineering services in Norway, Europe, Asia, the United Kingdom, and internationally. The company operates through three segments: Well Services; Operations; and Projects & Engineering. The Well Services segment provides casing and tubular running services, including automated and conventional; drilling tool and tubular rental services; and specialist well intervention products and services for exploration wells and for production. The Operations segment engages in the production of drilling and well completion on client's rigs. This segment is also involved in the slot recovery, plug and abandonment, work-overs, and maintenance activities; and provision of platform drilling services on both fixed production platforms and on floating production platforms with subsea blowout preventers along with the management and performance of the services on leased Jack-up rigs. The Projects & Engineering segment offers engineering and integrity services, including design and engineering to building supervision; and project management and operational support for units in operation, newbuild projects, and SPS/RS recertification projects and yard stays. The company was founded in 1973 and is headquartered in Aberdeen, the United Kingdom.
Earnings Per Share
As for profitability, ODFJELL TECHNOLOGY has a trailing twelve months EPS of kr7.92.
PE Ratio
ODFJELL TECHNOLOGY has a trailing twelve months price to earnings ratio of 7.47. Meaning, the purchaser of the share is investing kr7.47 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 4.81B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ODFJELL TECHNOLOGY’s EBITDA is 23.06.
More news about ODFJELL TECHNOLOGY.
6. BAKKAFROST (BAKKA.OL)
11.7% sales growth and 13.83% return on equity
P/F Bakkafrost, together with its subsidiaries, produces and sells salmon products under the Bakkafrost and Havsbrún brands in North America, Western Europe, Eastern Europe, Asia, and internationally. It operates through four segments: Farming FO; Farming SCT; Value Added Products; and Fishmeal, Oil and Fish Feed. The company is involved in the breeding and on-growing of salmon; harvesting, sale, and distribution of salmon; salmon farming, harvest, filleting, sales, and administration; and production of skinless and boneless portions of salmon. It also produces and sells fishmeal, fish oil, and fish feed. In addition, it engages in production of styrofoam boxes, and biogas and fertilizer; and operates trading of fishes, lumpfish farming business, and freight transportation of goods, as well as produce and sell canned fish products. P/F Bakkafrost was founded in 1968 and is headquartered in Glyvrar, Denmark.
Earnings Per Share
As for profitability, BAKKAFROST has a trailing twelve months EPS of kr11.17.
PE Ratio
BAKKAFROST has a trailing twelve months price to earnings ratio of 51.79. Meaning, the purchaser of the share is investing kr51.79 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.83%.
Volume
Today’s last reported volume for BAKKAFROST is 46611 which is 35% below its average volume of 71712.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25%, now sitting on 7.54B for the twelve trailing months.
More news about BAKKAFROST.
